Find supporting resources for our platform.
eProtein Discovery™: An overview
Get to know more about this platform which gives you soluble, active proteins in 48 hours for your downstream applications.
Nuclera helps accelerate understanding of COVID-19
Nuclera collaborates with the University of Southampton to understand COVID-19.
Application Note: Rapid cell-free expression and solubility screening to obtain active human VEGF with eProtein Discovery™ platform
VEGF is a key regulator of angiogenesis and plays a central role in the process of tumor growth, making it an appealing target for anticancer therapeutics. This platform demonstrates time-saving for both soluble construct identification and micrograms of active proteins obtained in 48 hours.
Video – Intro to eProtein Discovery™
An overview of eProtein Discovery, a rapid protein access system located on your benchtop, which enables you to go from DNA to protein in less than 48 hours.
Poster: Rapid cell-free expression and purification screen through digital microfluidics on eProtein Discovery
A visual summary of the background, methods and results is illustrated in this poster from an eProtein Discovery study.
Customize DNA constructs (eGene) with pre-set fusion tags to optimize protein expression
Nuclera has developed eGene™ Prep Kits to rapidly convert your Gene of Interest into expression cassettes that are immediately compatible with eProtein Discovery™ reagents for Cell-Free Protein Synthesis (CFPS). CFPS utilizes linear DNAs (eGene™ constructs) as one of its ingredients to power the cell-free machinery to produce protein.